THE CONTRIBUTION OF HELICAL POTENTIAL TO THE IN-VITRO RECEPTOR-BINDING ACTIVITY OF A NEUROPEPTIDE-Y N-TERMINAL DELETION FRAGMENT

被引:17
作者
DOUGHTY, MB
HU, LQ
机构
[1] Department of Medicinal Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas
关键词
D O I
10.1002/bip.360330806
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In its dimeric form neuropeptide Y (NPY) folds into a compact structure in which the antiparallel oriented proline and alpha-helices apparently associate to form a primitive hydrophobic core. To investigate the contribution of helical stability to the receptor binding activity of NPY and its N-terminal deletion fragments, we synthesized and studied the solution conformational properties and in vitro activities of NPY, N(alpha)-acetyl-NPY2-36, NPY15-36, N(alpha)-propionyl-NPY15-36, and N(alpha)-succinyl-NPY15-36. NPY15-36 is significantly less helical than both NPY and N(alpha)-acetyl-NPY2-36, and this decreased helical potential is attributed to the absence of the intramolecular stabilizing interactions afforded by the proline helix in the latter analogues. However, in accord with the helix dipole model, the helical potential of NPY15-36 is significantly increased by N-terminal succinylation, whereas propionylation has no effect. In addition to an increase in helical potential, N(alpha)-succinyl-NPY-15-36 is 2.5 and 4.6 times more active than NPY15-36 and N(alpha)-propionyl-NPY15-36, respectively, and is equipotent with N(alpha)-acetyl-NPY2-36 in displacing 1 n M [H-3]-NPY from specific binding sites in rat brain membranes. The demonstration of a positive correlation between % alpha-helix content and in vitro binding activity suggests that the helical potential of N-terminal NPY deletion fragments contributes to their in vitro activity in the rat brain, and that a second role of the proline helix might be to stabilize the receptor-active conformation of the NPY alpha-helix. (C) 1993 John Wiley & Sons, Inc.
引用
收藏
页码:1195 / 1206
页数:12
相关论文
共 44 条
[1]   MOLECULAR-STRUCTURE OF MAMMALIAN NEUROPEPTIDE-Y - ANALYSIS BY MOLECULAR-CLONING AND COMPUTER-AIDED COMPARISON WITH CRYSTAL-STRUCTURE OF AVIAN HOMOLOG [J].
ALLEN, J ;
NOVOTNY, J ;
MARTIN, J ;
HEINRICH, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (08) :2532-2536
[2]  
BECKSICKINGER AG, 1990, INT J PEPT PROT RES, V36, P522
[3]   MECHANISMS OF PROTEIN AND POLYPEPTIDE HELIX INITIATION [J].
BLAGDON, DE ;
GOODMAN, M .
BIOPOLYMERS, 1975, 14 (01) :241-245
[4]   X-RAY-ANALYSIS (1.4-A RESOLUTION) OF AVIAN PANCREATIC-POLYPEPTIDE - SMALL GLOBULAR PROTEIN HORMONE [J].
BLUNDELL, TL ;
PITTS, JE ;
TICKLE, IJ ;
WOOD, SP ;
WU, CW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (07) :4175-4179
[5]   SYNTHESIS AND HYPERTENSIVE ACTIVITY OF NEUROPEPTIDE-Y FRAGMENTS AND ANALOGS WITH MODIFIED N-TERMINI OR C-TERMINI OR D-SUBSTITUTIONS [J].
BOUBLIK, JH ;
SCOTT, NA ;
BROWN, MR ;
RIVIER, JE .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) :597-601
[6]   PROBING THE FUNCTIONAL CONFORMATION OF NEUROPEPTIDE-Y THROUGH THE DESIGN AND STUDY OF CYCLIC ANALOGS [J].
BOUVIER, M ;
TAYLOR, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (06) :1145-1155
[7]   CIRCULAR DICHROIC ANALYSIS OF PROTEIN CONFORMATION - INCLUSION OF BETA-TURNS [J].
CHANG, CT ;
WU, CSC ;
YANG, JT .
ANALYTICAL BIOCHEMISTRY, 1978, 91 (01) :13-31
[8]   SPECIFIC [H-3] PROPIONYL-NEUROPEPTIDE-Y (NPY) BINDING IN RABBIT AORTIC MEMBRANES - COMPARISONS WITH BINDING IN RAT-BRAIN AND BIOLOGICAL RESPONSES IN RAT VAS-DEFERENS [J].
CHANG, RSL ;
LOTTI, VJ ;
CHEN, TB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 151 (03) :1213-1219
[9]   CONFORMATIONAL PARAMETERS FOR AMINO-ACIDS IN HELICAL, BETA-SHEET, AND RANDOM COIL REGIONS CALCULATED FROM PROTEINS [J].
CHOU, PY ;
FASMAN, GD .
BIOCHEMISTRY, 1974, 13 (02) :211-222
[10]   PRESYNAPTIC INHIBITION BY NEUROPEPTIDE-Y IN RAT HIPPOCAMPAL SLICE INVITRO IS MEDIATED BY A Y2 RECEPTOR [J].
COLMERS, WF ;
KLAPSTEIN, GJ ;
FOURNIER, A ;
STPIERRE, S ;
TREHERNE, KA .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 102 (01) :41-44